Skip to content
healthcare.dev
Get a free key

ANASCORP

NDC 66621-0150, centruroides (scorpion) immune F(ab)2 (equine), injection, powder, lyophilized, for solution, from Rare Disease Therapeutics, Inc.

Product NDC
66621-0150
Status
Listed
Labeler
Rare Disease Therapeutics, Inc
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125335
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66621-0150 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CENTRUROIDES FAB2 ANTIVENIN (EQUINE)7 mg/mL

Pharmacologic classes

Antivenin [EPC]; Antivenins [CS]; Passively Acquired Immunity [PE]; Venom Neutralization [MoA]

Package NDCNDC-11Package
66621-0150-2666210150021 VIAL in 1 CARTON (66621-0150-2) / 10 mL in 1 VIAL (66621-0150-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 66621-0150 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66621-0150 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66621-0150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.